Contract 75A50125C00002
Sanofi Vaccines Us Inc. · Department Of Health And Human Services · January 31, 2025
Sanofi Vaccines Us Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on January 31, 2025 for $53.21 million of work in biological product (except diagnostic) manufacturing. Performance is in Swiftwater, PA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 19, 2026. If all options are exercised, the contract could reach $79.84 million.
Contract details
- PIID
- 75A50125C00002
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical- Other
- Place of performance
- Swiftwater, PA
- First action
- January 31, 2025
- Latest action
- March 19, 2026
Description
THE PURPOSE OF THIS MODIFICATION: 1) TO REPLACE KRISTIN KELLY WITH SARAH HUMPHREY AS PRINCIPAL INVESTIGATOR ON THE CONTRACT (SEE FOLLOW-ON PAGE). 2) ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME AN
Modification timeline
-
March 19, 2026Mod P00003THE PURPOSE OF THIS MODIFICATION: 1) TO REPLACE KRISTIN KELLY WITH SARAH HUMPHREY AS PRINCIPAL INVESTIGATOR ON THE CONTRACT (SEE FOLLOW-ON PAGE). 2) ALL OTHER$0
-
January 30, 2026Mod P00002MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE$26.61M
-
July 17, 2025Mod P00001MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE$17.71M
-
January 31, 2025Base awardMAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE$8.89M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Life Technologies Corporation | Department Of Health And Human Services | March 17, 2026 | $18.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50125C00002?
Contract 75A50125C00002 is a federal contract awarded to Sanofi Vaccines Us Inc. by Department Of Health And Human Services on January 31, 2025 for $53.21 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75A50125C00002?
Sanofi Vaccines Us Inc. won contract 75A50125C00002 from Department Of Health And Human Services.
How much is contract 75A50125C00002 worth?
Contract 75A50125C00002 has obligated $53.21 million to date, with a total potential value of $79.84 million if all options are exercised.